Paper8759268
Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.
Elder MJ and 2 others. Br J Ophthalmol, 1996. Cited by 41 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid. Papers, record 8759268. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8759268
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents | Major topic |
| Conjunctivitis | Major topic |
| Pemphigoid, Benign Mucous Membrane | Major topic |
| Sulfapyridine | Major topic |
| Administration, Oral | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,646,069 | Erythema elevatum diutinum--vesicular lesions and sulphone response. | Br J Dermatol | 1968 | https://conductscience.org/library/papers/5646069 | PubMed |
| 2 | 13,845,241 | Dermatitis herpetiformis with acantholysis or pemphigus with response to sulfonamides: report of two cases. | Arch Dermatol | 1960 | https://conductscience.org/library/papers/13845241 | PubMed |
| 3 | 5,120,174 | Benign mucous membrane pemphigoid. | Arch Dermatol | 1971 | https://conductscience.org/library/papers/5120174 | PubMed |
| 4 | 4,141,602 | Immunosuppressive and cytotoxic drugs in dermatology. | Arch Dermatol | 1974 | https://conductscience.org/library/papers/4141602 | PubMed |
| 5 | 848,360 | Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases. | Acta Med Scand | 1977 | https://conductscience.org/library/papers/848360 | PubMed |
| 6 | 324,403 | Bullous pemphigoid responding to sulfapyridine and the sulfones. | Arch Dermatol | 1977 | https://conductscience.org/library/papers/324403 | PubMed |
| 7 | 868,943 | Autoimmune phenomena in ocular cicatricial pemphigoid. | Am J Ophthalmol | 1977 | https://conductscience.org/library/papers/868943 | PubMed |
| 8 | 334,088 | Electron microscopic studies in dermatitis herpetiformis in relation to the pattern of immune deposits in the skin. | Arch Dermatol Res (1975) | 1977 | https://conductscience.org/library/papers/334088 | PubMed |
| 9 | 21,720 | Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis. | Br Med J | 1977 | https://conductscience.org/library/papers/21720 | PubMed |
| 10 | 528,697 | Sulfones and sulfonamides in dermatology today. | J Am Acad Dermatol | 1979 | https://conductscience.org/library/papers/528697 | PubMed |
| 11 | 537,759 | The acute manifestations of ocular cicatricial pemphigoid: diagnosis and treatment. | Ophthalmology | 1979 | https://conductscience.org/library/papers/537759 | PubMed |
| 12 | 7,015,218 | Ocular cicatricial pemphigoid. | Ophthalmology | 1981 | https://conductscience.org/library/papers/7015218 | PubMed |
| 13 | 7,037,880 | Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. | J Am Acad Dermatol | 1982 | https://conductscience.org/library/papers/7037880 | PubMed |
| 14 | 7,048,180 | Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. | Ophthalmology | 1982 | https://conductscience.org/library/papers/7048180 | PubMed |
| 15 | 6,353,928 | Immunosuppressive therapy in ocular cicatricial pemphigoid. | Am J Ophthalmol | 1983 | https://conductscience.org/library/papers/6353928 | PubMed |
| 16 | 6,142,465 | A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route. | Pharmatherapeutica | 1984 | https://conductscience.org/library/papers/6142465 | PubMed |
| 17 | 2,860,942 | Which component of sulphasalazine is active in rheumatoid arthritis? | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/2860942 | PubMed |
| 18 | 2,861,876 | Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. | Br J Rheumatol | 1985 | https://conductscience.org/library/papers/2861876 | PubMed |
| 19 | 2,864,155 | Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. | Clin Pharmacokinet | 1985 | https://conductscience.org/library/papers/2864155 | PubMed |
| 20 | 2,866,061 | Sulphasalazine and derivatives, natural killer activity and ulcerative colitis. | Clin Sci (Lond) | 1985 | https://conductscience.org/library/papers/2866061 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32,313,985 | Signaling lipids as diagnostic biomarkers for ocular surface cicatrizing conjunctivitis. | J Mol Med (Berl) | 2020 | https://conductscience.org/library/papers/32313985 | PubMed |
| 28,106,896 | The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on. | Eye (Lond) | 2017 | https://conductscience.org/library/papers/28106896 | PubMed |
| 20,030,429 | Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management. | Drugs Aging | 2010 | https://conductscience.org/library/papers/20030429 | PubMed |
| 18,392,628 | [Mucous membrane pemphigoid with ocular involvement. Part II: therapy]. | Ophthalmologe | 2008 | https://conductscience.org/library/papers/18392628 | PubMed |
| 18,360,613 | Therapy of autoimmune bullous diseases. | Ther Clin Risk Manag | 2007 | https://conductscience.org/library/papers/18360613 | PubMed |
| 15,967,079 | Ocular cicatricial pemphigoid: manifestations and management. | Curr Allergy Asthma Rep | 2005 | https://conductscience.org/library/papers/15967079 | PubMed |
| 12,831,291 | Autoimmune bullous dermatoses in the elderly: diagnosis and management. | Drugs Aging | 2003 | https://conductscience.org/library/papers/12831291 | PubMed |
| 12,535,507 | Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. | Cochrane Database Syst Rev | 2003 | https://conductscience.org/library/papers/12535507 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8759268
GET https://conductscience.org/api/papers/v1/8759268/references?page=2